Dr. Richard T. Penson, Dr. Bradley J. Monk, and Dr. Krishnansu S. Tewari discuss the evolution of cervical cancer treatment over the past five years.
By Peter J. Sciavolino, PhD
Advertisement
Articles by By Peter J. Sciavolino, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026
5